Journals / Türk Anestezi ve Reanimasyon Dergisi / 2008 / Cilt: 36 - Sayı: 4

Multiple sclerosis and anaesthesia

Multiple skleroz ve anestezi

Pages
213–221
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper, etiologies, progress and the anaesthetic management of MS was discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system affecting primarily women at the age between 30-40 years.
📊
Key Findings & Data:The disease may affect many organ systems and the insufficiency caused in these systems may affect the anaesthetic management.
💡
Conclusion & Impact:In this paper, etiologies, progress and the anaesthetic management of MS was discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system affecting primarily women at the age between 30-40 years. The disease may affect many organ systems and the insufficiency caused in these systems may affect the anaesthetic management. The main point about MS is that it may have different symptoms and the degree of the disease may be changing. Although, all anaesthetic techniques may cause exacerbation of the disease, general anaesthesia and epidural anaesthesia with low concentration of lidocain seems safer than spinal anaesthesia. Patient should be informed that the disease may exacerbate after the surgery and the anaesthesia. Any potential efficacy, risks and complications of the anaesthetic technique should be explained. Evaluating and recording preoperative and postoperative neurological and respiratory data of the patient is important in respect to determine the postoperative effects of the surgery and the anaesthesia. Pharmacological treatment of the patient should be analyzed and if necessary replacement therapy be ordered. Body temperature should be monitored closely and hyperthermia should be prevented. In this paper, etiologies, progress and the anaesthetic management of MS was discussed.

Özet

Multipl skleroz (MS) özellikle 30-40 yaşlarında kadınları etkileyen santral sinir sisteminin kronik demiyelinizan bir hastalığıdır. Hastalık, pek çok organ sistemini etkileyebilir ve bu sistemlerde yetmezlik oluşturması durumunda hastaya verilecek anesteziyi de etkiler. MS hakkında anımsanması gereken en önemli nokta, çok çeşitli semptomlarının olması ve semptomlarının ağırlığının değişik derecelerde görülebilmesidir. Bütün anestezik teknikler hastalık semptomlarının alevlenmesi ile ilişkili olsa da, genel anestezi ve düşük konsantrasyonda lokal anestezikle uygulanacak epidural anestezinin, spinal anesteziden daha güvenli olabileceği bildirilmektedir. Hastalar, MS semptomlarının cerrahi ve anestezi sonrası alevlenebileceği konusunda bilgilendirilmeli ve uygulanacak anestezi tekniğinin olası yararları, riskleri ve komplikasyonları anlatılmalıdır. Preoperatif ve postoperatif nörolojik ve solunum sisteminin değerlendirilmesinin yapılıp bulguların kaydedilmesi, anestezi ve cerrahinin MS üzerindeki etkilerinin değerlendirilmesi açısından önemlidir. Hastaların kullandığı farmakolojik tedavi incelenmeli ve gerekli ise replasman tedavileri yapılmalıdır. Hastaların vücut ısıları sürekli monitorize edilmeli ve hipertermiden kaçınılmalıdır. Bu derlemede, multipl sklerozun etiyolojisi, ilerlemesi ve anestezik açıdan dikkat edilmesi gereken konular anlatılmaya çalışılmıştır.

🔖

Cite This Article

ŞAHİN, A., AYPAR, Ü., UZUN, Ş., ARUN, O. (2022). Multiple sclerosis and anaesthesia. Türk Anestezi ve Reanimasyon Dergisi, Cilt: 36 - Sayı: 4, 213–221. https://ajindex.com/articles/619960

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Morgan GE, Mikhail MS, Murray MJ, Larson CP. Clinical Anesthesiology. 3rd ed. New York, NY: McGraw Hill; 2002:587-8
  2. Kaufman MD, Johnson SK, Moyer D, Bivens J, Norton HJ. Multiple sclerosis: severity and progression rate in African Americans compared with whites. Am J Phys Mcd Rehabil 2003; 82:582-90
  3. Rosati G, Aiello I, Pirastru MI, et al. Epidemiology of multiple sclerosis in northwestern Sardinia: further evidence for higher frequency in Sardinians compared to other Italiens. Neuroepidemiology 1996; 15:10-9
  4. Svenningsson A, Runmaker B, Lycke J, Andersen O. Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden. Acta Neurol Scand 1990; 82:161-8
  5. Courtney SW, Burks J, Barkowsky A, Damiri P, Richman C. All About Multiple Sclerosis. Cherry Hill. NJ: Multiple Sclerosis Association of America; 2002
  6. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple Sclerosis. N Engl J Med 2000; 343:938-52
  7. Sadovnick AD, Armstrong H, Rice GP, et al. A population base study of multiple sclerosis in twins: update. Ann Neurol 1993; 33:281-5
  8. Weinshenker BG, Santrach P, Bissonet AS, et al. Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology 1998; 51:742-7
  9. Haines JL, Ter-Minassian M, Bazyk A, et al. A complete genomic screen for multiple sclerosis underscores the role for the major histocompatibility complex. Nat Genet 1996; 13:469-71
  10. Kuokkanen S, Gschwend M, Rioux JD, et al. Genome wide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet 1997; 61:1379-87
  11. Robertson NP, Compston DAS. Prognosis in multiple sclerosis: genetic factors. In: Siva A, Kesselring J, Thompson AJ, editors. Frontiers in multiple sclerosis. Volume 2. London: Martin Dunitz; 1999. pp. 51-61
  12. Elian M, Nightingale S, Dean G. Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and West Indies. J Neurol Neurosurg Psychiatry 1990; 53:906-11
  13. Compston A. Risk factors for multiple sclerosis: race or place? J Neurol Neurosurg Psychiatry 1990; 53:821-3
  14. Carrigan DR, Harrington D, Knox KK. Subacute leukoencephalitis caused by CNS infection with human herpesvirus-6 manifesting as acute multiple sclerosis. Neurology 1996; 47:145-8
  15. Sriram S, Stratton CW, Yao S, et al. Chlamiydia pneumonia infection of the central nervous system in multiple sclerosis. Ann Neurol 1999; 46:6-14
  16. Fourrie